Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.
about
Screening of healthcare workers for tuberculosis: development and validation of a new health economic model to inform practiceIdentification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infectionBoosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsPersistence of the immune response induced by BCG vaccination.Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosisRecombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopesWhat has Karonga taught us? Tuberculosis studied over three decades.Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancyThe success and failure of BCG - implications for a novel tuberculosis vaccine.Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom.Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccinesThe influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations.
P2860
Q28731558-A69D1A9D-6ED8-45E4-81C3-AA3FB244F9A3Q30408875-293861E2-DFEB-492C-A85A-4CE7BB17453EQ30441556-196E5B3C-6B79-4447-915F-AB73C440C3ECQ33303660-C1091F51-1F1D-4457-B021-BF25557E374EQ33316559-C05E2551-EC91-4CBC-9817-F75F02C95ECCQ34306108-C6219DBC-D3B3-4A6B-AEFE-96FF647449E6Q34361636-9F4C966C-D9B7-4522-ADB5-548B6623C6B6Q34985591-F56DDE0C-408A-4438-BF1E-DB1245D47E6EQ35737870-6D940106-A001-4309-9D73-0801F5225795Q35748899-13669D45-D03F-4F6F-89A4-6EFEDED0B50FQ36191944-7BAF1339-717A-4FE1-9F1A-E9A1AE74C7ECQ36575596-7A47698A-5477-45E7-BE9A-560354EC48AAQ36736465-EA1DD463-FC9C-4472-89EA-FDCFAA8128F0Q38529413-40875DBF-BC1E-41B5-9DFD-F22E144887C7Q39585280-5C97785C-ABA3-4D48-86AE-A2F11AD3C157Q42188479-16B1C47A-9BBC-4F02-82E1-5A4AB4274E93
P2860
Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Interferon-gamma and skin test ...... other species of mycobacteria.
@en
Interferon-gamma and skin test ...... other species of mycobacteria.
@nl
type
label
Interferon-gamma and skin test ...... other species of mycobacteria.
@en
Interferon-gamma and skin test ...... other species of mycobacteria.
@nl
prefLabel
Interferon-gamma and skin test ...... other species of mycobacteria.
@en
Interferon-gamma and skin test ...... other species of mycobacteria.
@nl
P2093
P2860
P1476
Interferon-gamma and skin test ...... other species of mycobacteria.
@en
P2093
B Nazareth
P E M Fine
P2860
P304
P356
10.1046/J.1365-2249.2003.02272
P577
2003-11-01T00:00:00Z